It was found that lncRNA SOX2OT reduced the methylation level of SOX2 by interacting with ALKBH5, thus improving the SOX2 expression and activating the Wnt5a/β-catenin signaling pathway to promote TMZ resistance in glioma cells (59). This evidence concerns the gene SOX2 and central nervous system cancer.